Smith & Nephew plc (SNN)

Market Cap	12.18B
Revenue (ttm)	5.81B
Net Income (ttm)	412.00M
Shares Out	873.49M
EPS (ttm)	0.47
PE Ratio	29.56
Forward PE	14.52
Dividend	$0.74 (2.58%)
Ex-Dividend Date	Mar 28, 2025

Volume	598,259
Open	28.45
Previous Close	28.03
Day's Range	28.41 - 28.70
52-Week Range	23.65 - 31.72
Beta	0.72
Analysts	Hold
Price Target	27.00 (-5.13%)
Earnings Date	Feb 25, 2025

About SNN

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. It operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction proced...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Nov 16, 1999
• Employees: 18,060
• Stock Exchange: NYSE
• Ticker Symbol: SNN
• Website: https://www.smith-nephew.com

Financial Performance

In 2024, Smith & Nephew's revenue was $5.81 billion, an increase of 4.70% compared to the previous year's $5.55 billion. Earnings were $412.00 million, an increase of 56.65%.

Analyst Forecast

According to 3 analysts, the average rating for SNN stock is "Hold." The 12-month stock price forecast is $27.0, which is a decrease of -5.13% from the latest price.

Price Target

$27.0

(-5.13% downside)

Analyst Consensus: Hold